These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 34889373

  • 1. How to avoid the problem of erythrocyte alloimmunization in sickle cell disease.
    Pirenne F, Floch A, Habibi A.
    Hematology Am Soc Hematol Educ Program; 2021 Dec 10; 2021(1):689-695. PubMed ID: 34889373
    [Abstract] [Full Text] [Related]

  • 2. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR.
    Transfus Med Rev; 2019 Jan 10; 33(1):12-23. PubMed ID: 30122266
    [Abstract] [Full Text] [Related]

  • 3. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.
    Shih AW, Yan MTS, Elahie AL, Barty RL, Liu Y, Berardi P, Azzam M, Siddiqui R, Parvizian MK, Mcdougall T, Heddle NM, Al-Habsi KS, Goldman M, Cote J, Athale U, Verhovsek MM.
    Transfus Med; 2020 Aug 10; 30(4):263-274. PubMed ID: 32432400
    [Abstract] [Full Text] [Related]

  • 4. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
    Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM.
    Blood; 2013 Aug 08; 122(6):1062-71. PubMed ID: 23723452
    [Abstract] [Full Text] [Related]

  • 5. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Muniz JG, Arnoni C, Medeiros R, Vendrame T, Cortez A, S Afonso J, Latini F, Castilho L, Girão M.
    Transfusion; 2021 Aug 08; 61(8):2458-2467. PubMed ID: 34121200
    [Abstract] [Full Text] [Related]

  • 6. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA, Campbell AD, Davenport RD, Osei-Akoto A, Hugan S, Asamoah A, Schonewille H.
    Transfusion; 2019 Jun 08; 59(6):2016-2022. PubMed ID: 30758856
    [Abstract] [Full Text] [Related]

  • 7. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
    Miller ST, Kim HY, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).
    Transfusion; 2013 Apr 08; 53(4):704-9. PubMed ID: 22804353
    [Abstract] [Full Text] [Related]

  • 8. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
    Coleman S, Westhoff CM, Friedman DF, Chou ST.
    Transfusion; 2019 Jul 08; 59(7):2282-2291. PubMed ID: 31021439
    [Abstract] [Full Text] [Related]

  • 9. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.
    Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, Kameka M, Kwiatkowski JL, Pirenne F, Shi PA, Stowell SR, Thein SL, Westhoff CM, Wong TE, Akl EA.
    Blood Adv; 2020 Jan 28; 4(2):327-355. PubMed ID: 31985807
    [Abstract] [Full Text] [Related]

  • 10. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Chonat S, Arthur CM, Zerra PE, Maier CL, Jajosky RP, Yee MEM, Miller MJ, Josephson CD, Roback JD, Fasano R, Stowell SR.
    Transfus Clin Biol; 2019 May 28; 26(2):130-134. PubMed ID: 30979566
    [Abstract] [Full Text] [Related]

  • 11. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.
    Israelyan N, Vege S, Friedman DF, Zhang Z, Uter S, Fasano RM, Yee M, Piccone C, Kelly S, Hankins JS, Zheng Y, Westhoff CM, Chou ST.
    Transfusion; 2024 Mar 28; 64(3):526-535. PubMed ID: 38289184
    [Abstract] [Full Text] [Related]

  • 12. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C, Liem RI, Mack AK, Kingsberry P, Ramsey G, Thompson AA.
    Pediatr Blood Cancer; 2013 Sep 28; 60(9):1487-91. PubMed ID: 23508932
    [Abstract] [Full Text] [Related]

  • 13. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.
    Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA.
    Transfusion; 2014 Aug 28; 54(8):2034-44. PubMed ID: 24571485
    [Abstract] [Full Text] [Related]

  • 14. Red Blood Cell Alloimmunization in Transfused Patients With Sickle Cell Disease in Sub-Saharan Africa; a Systematic Review and Meta-Analysis.
    Boateng LA, Ngoma AM, Bates I, Schonewille H.
    Transfus Med Rev; 2019 Jul 28; 33(3):162-169. PubMed ID: 31345590
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.
    Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA.
    Transfusion; 2014 Jan 28; 54(1):86-97. PubMed ID: 23692415
    [Abstract] [Full Text] [Related]

  • 16. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy.
    Ambruso DR, Githens JH, Alcorn R, Dixon DJ, Brown LJ, Vaughn WM, Hays T.
    Transfusion; 1987 Jan 28; 27(1):94-8. PubMed ID: 3810834
    [Abstract] [Full Text] [Related]

  • 17. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R, Hendrickson JE.
    Transfus Clin Biol; 2019 May 28; 26(2):112-115. PubMed ID: 30857806
    [Abstract] [Full Text] [Related]

  • 18. Alloimmunization in transfused patients with constitutional anemias in Norway.
    Furuseth MT, Alme C, Garvik LJ, Hellebostad M, Bechensteen AG, Akkök ÇA.
    Transfus Apher Sci; 2021 Oct 28; 60(5):103257. PubMed ID: 34420880
    [Abstract] [Full Text] [Related]

  • 19. Alloimmunization and hyperhemolysis in sickle cell disease.
    Pirenne F, Pondarré C.
    Hematology Am Soc Hematol Educ Program; 2023 Dec 08; 2023(1):653-659. PubMed ID: 38066873
    [Abstract] [Full Text] [Related]

  • 20. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.
    Fasano RM, Chou ST.
    Transfus Med Rev; 2016 Oct 08; 30(4):197-201. PubMed ID: 27345938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.